Earnings Call · Q4 FY2022·2023-02-22

Q4 22EPS +2.94%·Rev n/aQ3 22EPS +12.12%·Rev n/aQ2 22EPS +20.00%·Rev n/aQ1 22EPS +22.73%·Rev n/a⚠ consensus missing

MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

Debra Hart — Head of Investor Relations

Carl Hull — Chief Executive Officer

Kevin Herde — Chief Financial Officer

+8.2%1d on move date+7.6% vs SPY3d+4.5%5d+8.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRVI calls or request research access.

More MRVI calls Browse calls Request research access